|
US6696561B1
(en)
*
|
1909-07-09 |
2004-02-24 |
Basf Aktiengesellschaft |
Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
|
|
US6251647B1
(en)
*
|
1993-12-06 |
2001-06-26 |
The Rockefeller University |
Auxiliary genes and proteins of methicillin resistant bacteria and antagonists thereof
|
|
EP1091004B1
(en)
*
|
1994-06-24 |
2009-02-25 |
Innogenetics N.V. |
Simultaneous detection, identification and differentiation of Mycobacterium species using a hybridization assay
|
|
US20020055101A1
(en)
|
1995-09-11 |
2002-05-09 |
Michel G. Bergeron |
Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
|
|
US5994066A
(en)
*
|
1995-09-11 |
1999-11-30 |
Infectio Diagnostic, Inc. |
Species-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
|
|
US6514746B1
(en)
|
1995-09-15 |
2003-02-04 |
Essential Therapeutics, Inc. |
Staphylococcus aureus histidine protein kinase essential genes
|
|
US6037123A
(en)
|
1995-09-15 |
2000-03-14 |
Microcide Pharmaceuticals, Inc. |
Methods of screening for compounds active on Staphylococcus aureus target genes
|
|
US5962283A
(en)
|
1995-12-07 |
1999-10-05 |
Diversa Corporation |
Transminases and amnotransferases
|
|
US6403337B1
(en)
*
|
1996-01-05 |
2002-06-11 |
Human Genome Sciences, Inc. |
Staphylococcus aureus genes and polypeptides
|
|
US6833253B2
(en)
*
|
1996-01-05 |
2004-12-21 |
Human Genome Sciences, Inc. |
Staphylococcus aureus polynucleotides and polypeptides
|
|
JPH11503619A
(ja)
*
|
1996-01-19 |
1999-03-30 |
スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー |
スタフィロコッカス・アウレウスのメチオニル−ｔＲＮＡシンセターゼ
|
|
US5750387A
(en)
*
|
1996-01-19 |
1998-05-12 |
Smithkline Beecham P.L.C. |
DNA encoing leucyl TRNA synthetase from staphylococcus aureus
|
|
GB9601067D0
(en)
*
|
1996-01-19 |
1996-03-20 |
Smithkline Beecham Plc |
Novel compounds
|
|
EP0785269A1
(en)
*
|
1996-01-19 |
1997-07-23 |
Smithkline Beecham Plc |
Histidyl-tRNA synthetase of Staphylococcus aureus
|
|
US6010881A
(en)
|
1996-02-20 |
2000-01-04 |
Smithkline Beecham Corporation |
RibG
|
|
US5882891A
(en)
*
|
1996-02-20 |
1999-03-16 |
Smithkline Beecham Corporation |
Ferrichrome transport ATP-binding protein
|
|
WO1997030149A1
(en)
*
|
1996-02-20 |
1997-08-21 |
Smithkline Beecham Corporation |
Novel era
|
|
US5989864A
(en)
*
|
1996-10-29 |
1999-11-23 |
Smithkline Beecham Corporation |
DNA encoding spo-rel polypeptides
|
|
GB9605381D0
(en)
*
|
1996-03-14 |
1996-05-15 |
Smithkline Beecham Plc |
Novel compounds
|
|
GB9607991D0
(en)
*
|
1996-04-18 |
1996-06-19 |
Smithkline Beecham Plc |
Novel compounds
|
|
GB9608000D0
(en)
*
|
1996-04-18 |
1996-06-19 |
Smithkline Beecham Plc |
Novel compounds
|
|
GB9607993D0
(en)
*
|
1996-04-18 |
1996-06-19 |
Smithkline Beecham Plc |
Novel compounds
|
|
US6165989A
(en)
*
|
1996-05-14 |
2000-12-26 |
Smithkline Beecham Corporation |
Era of Streptococcus pneumoniae
|
|
EP0956289A4
(en)
|
1996-08-16 |
2004-10-13 |
Smithkline Beecham Corp |
NOVEL PROKARYOTA POLYNUCLEOTIDES AND POLYPEPTIDES AND USES THEREOF
|
|
US6995254B1
(en)
|
1996-08-28 |
2006-02-07 |
Affinium Pharmaceuticals, Inc. |
Polynucleotide encoding the enoyl-acyl carrier protein reductase of Staphylococcus aureus, FAB I
|
|
DE69735225T2
(de)
*
|
1996-08-28 |
2006-11-02 |
Affinium Pharmaceuticals, Inc., Toronto |
Fab I Enoyl-ACP-Reduktase aus Staphylokokken
|
|
US6107071A
(en)
|
1996-09-24 |
2000-08-22 |
Smithkline Beecham Corporation |
Histidinol dehydrogenase
|
|
US6013505A
(en)
*
|
1996-10-08 |
2000-01-11 |
Smithkline Beecham Corporation |
Topoisomerase I
|
|
US6025156A
(en)
*
|
1996-10-15 |
2000-02-15 |
Smithkline Beecham Corporation |
Topoisomerase III
|
|
US6348584B1
(en)
|
1996-10-17 |
2002-02-19 |
John Edward Hodgson |
Fibronectin binding protein compounds
|
|
US6310192B1
(en)
*
|
1996-10-24 |
2001-10-30 |
Smithkline Beecham Corporation |
SigB
|
|
US6020160A
(en)
|
1996-10-24 |
2000-02-01 |
Smithkline Beecham Corporation |
RsbV-1 polynucleotides of Staphylococcus aureus
|
|
US6004556A
(en)
*
|
1996-10-24 |
1999-12-21 |
Smithkline Beecham Corporation |
Staphylococcus aureus RSBU-1
|
|
US5942419A
(en)
*
|
1996-10-24 |
1999-08-24 |
Smithkline Beecham P.L.C. |
RsbW-1 encoding nucleic acids
|
|
US20100267012A1
(en)
|
1997-11-04 |
2010-10-21 |
Bergeron Michel G |
Highly conserved genes and their use to generate probes and primers for detection of microorganisms
|
|
US20030049636A1
(en)
|
1999-05-03 |
2003-03-13 |
Bergeron Michel G. |
Species-specific, genus-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial and fungal pathogens and associated antibiotic resistance genes from clinical specimens for diagnosis in microbiology laboratories
|
|
EP1329510A3
(en)
*
|
1996-11-13 |
2003-08-27 |
SmithKline Beecham Corporation |
Staphylococcus FabD
|
|
US5827689A
(en)
*
|
1996-11-13 |
1998-10-27 |
Smithkline Beecham Corporation |
FabD polynucleotides
|
|
US6022706A
(en)
*
|
1997-04-09 |
2000-02-08 |
Smithkline Beecham Corporation |
Div1b
|
|
US5955304A
(en)
*
|
1997-01-02 |
1999-09-21 |
Smithkline Beecham Corporation |
DivIB
|
|
US6258934B1
(en)
|
1997-01-24 |
2001-07-10 |
Smithkline Beecham Corporation |
FabD
|
|
JP2001511004A
(ja)
*
|
1997-02-03 |
2001-08-07 |
イエール ユニバーシティ |
ＧｌｕｔＲＮＡ▲上Ｇｌｎ▼アミドトランスフェラーゼ−新規な必須の翻訳成分
|
|
US6150340A
(en)
*
|
1997-02-07 |
2000-11-21 |
Smithkline Beecham Corporation |
RNA-dependent amidotransferase from Staphylococcus aureus
|
|
US6410263B1
(en)
*
|
1997-02-07 |
2002-06-25 |
Smithkline Beecham Corporation |
Histidine kinase
|
|
CA2224085A1
(en)
*
|
1997-02-21 |
1998-08-21 |
Smithkline Beecham Corporation |
Aroe
|
|
US6210940B1
(en)
|
1997-04-18 |
2001-04-03 |
Smithkline Beecham Corporation |
Compounds
|
|
US6586578B1
(en)
|
1997-05-21 |
2003-07-01 |
Smithkline Beecham Corporation |
Defl
|
|
EP0881285A1
(en)
*
|
1997-05-29 |
1998-12-02 |
Smithkline Beecham Corporation |
D-Alanine transferase
|
|
US5891678A
(en)
*
|
1997-06-04 |
1999-04-06 |
Smithkline Beecham Corporation |
DNA encoding the SecA1 polypeptide of Staphylococcus aureus
|
|
US6204019B1
(en)
|
1997-06-04 |
2001-03-20 |
Smithkline Beecham Corporation |
Sec A2 from Streptococcus pneumoniae
|
|
EP0892055A3
(en)
*
|
1997-07-01 |
2002-03-20 |
Smithkline Beecham Corporation |
GidB polypeptides from Staphylococcus aureus
|
|
CA2236435A1
(en)
*
|
1997-07-01 |
1999-01-01 |
Smithkline Beecham Corporation |
Gida2
|
|
US5866367A
(en)
*
|
1997-07-01 |
1999-02-02 |
Smithkline Beecham Corporation |
Gidb
|
|
CA2236452A1
(en)
*
|
1997-07-01 |
1999-01-01 |
Smithkline Beecham Corporation |
Gida1
|
|
US6455323B1
(en)
|
1997-07-03 |
2002-09-24 |
Pharmacia & Upjohn Company |
Anti-bacterial methods and materials
|
|
US6838255B1
(en)
*
|
1997-07-03 |
2005-01-04 |
Smithkline Beecham Corporation |
MurC
|
|
EP0890644A3
(en)
*
|
1997-07-10 |
1999-09-29 |
Smithkline Beecham Corporation |
MurA gene from Staphylococcus aureus encoding DP-N-Acetylglucosamine enolpyruvyl transferase
|
|
US5889171A
(en)
*
|
1997-07-18 |
1999-03-30 |
Smithkline Beecham Corporation |
TarF
|
|
DE19731292A1
(de)
*
|
1997-07-21 |
1999-01-28 |
Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh |
Nucleinsäuremolekül, Kit und Verwendung
|
|
US5891670A
(en)
*
|
1997-07-23 |
1999-04-06 |
Smithkline Beecham Corporation |
Tetracycline resistance protein
|
|
EP0916729A3
(en)
*
|
1997-07-23 |
1999-08-04 |
Smithkline Beecham Corporation |
Novel reductase
|
|
EP0893500A3
(en)
*
|
1997-07-23 |
2001-10-17 |
Smithkline Beecham Corporation |
BmrU gene from Staphylococcus aureus
|
|
US5994096A
(en)
*
|
1997-07-25 |
1999-11-30 |
Smithkline Beecham Corporation |
Regulator
|
|
EP0896060A3
(en)
*
|
1997-08-08 |
2000-07-19 |
Smithkline Beecham Corporation |
RpoA gene from Staphylococcus aureus
|
|
US6258578B1
(en)
*
|
1997-08-11 |
2001-07-10 |
Smithkline Beecham Corporation |
His5
|
|
US6335433B1
(en)
|
1997-08-11 |
2002-01-01 |
Smithkline Beecham Corporation |
nrdD
|
|
US6180387B1
(en)
*
|
1997-08-11 |
2001-01-30 |
Smithkline Beecham Corporation |
Arginine deiminase
|
|
US6380370B1
(en)
*
|
1997-08-14 |
2002-04-30 |
Genome Therapeutics Corporation |
Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
|
|
US6225098B1
(en)
*
|
1997-08-25 |
2001-05-01 |
Smithkline Beecham Corporation |
UDP-N-acetylenolpyruvyglucosamine reductase
|
|
US6274361B1
(en)
*
|
1997-08-26 |
2001-08-14 |
Smithkline Beecham Corporation |
pth
|
|
US6331410B1
(en)
*
|
1997-08-29 |
2001-12-18 |
Smithkline Beecham Corp. |
Polynucleotides encoding a novel pyrR homolog
|
|
US6124119A
(en)
*
|
1997-09-04 |
2000-09-26 |
Smithkline Beecham Corporation |
mecB
|
|
US6284515B1
(en)
*
|
1997-09-03 |
2001-09-04 |
Smithkline Beecham Corporation |
Signal recognition particle polypeptides and polynucleotides
|
|
US6524813B1
(en)
*
|
1997-09-04 |
2003-02-25 |
Smithkline Beecham Corporation |
Polynucleotide encoding spo0J1 of Staphylococcus aureus
|
|
EP0970186A4
(en)
*
|
1997-09-04 |
2002-04-03 |
Smithkline Beecham Corp |
SPOoJ2 FROM STAPHYLOCOCCUS AUREUS
|
|
EP0905233A2
(en)
*
|
1997-09-04 |
1999-03-31 |
Smithkline Beecham Corporation |
Staphylococcus aureus trigger factor
|
|
US6080729A
(en)
*
|
1998-03-17 |
2000-06-27 |
Smithkline Beecham Corporation |
Spo0J2 of Staphylococcus aureus
|
|
US5888771A
(en)
*
|
1997-09-04 |
1999-03-30 |
Smithkline Beecham Corporation |
Integral membrane proteins from Streptoccus pneumoniae
|
|
EP0911405A3
(en)
*
|
1997-09-18 |
2000-01-19 |
SmithKline Beecham p.l.c. |
Gapdh
|
|
EP0905247A3
(en)
*
|
1997-09-25 |
1999-10-20 |
Smithkline Beecham Corporation |
MurF polynucleotides and polypeptides from Staphylococcus
|
|
US6013497A
(en)
*
|
1997-09-25 |
2000-01-11 |
Smithkline Beecham Corporation |
MurE
|
|
EP0905249A3
(en)
*
|
1997-09-25 |
1999-08-04 |
Smithkline Beecham Corporation |
Alcohol dehydrogenase
|
|
US6287807B1
(en)
*
|
1997-09-25 |
2001-09-11 |
Smithkline Beecham Corporation |
MurF
|
|
US6126937A
(en)
*
|
1997-10-03 |
2000-10-03 |
Smithkline Beecham Corporation |
ClpL
|
|
JP2001507945A
(ja)
*
|
1997-10-03 |
2001-06-19 |
スミスクライン・ビーチャム・コーポレイション |
スタフィロコッカス・アウレウスのリボソームリサイクリングファクター（ｆｒｒ）
|
|
US6251629B1
(en)
*
|
1997-10-07 |
2001-06-26 |
Smithkline Beecham Corporation |
ABC transporter
|
|
US5989858A
(en)
*
|
1997-10-28 |
1999-11-23 |
Smithkline Beecham Corporation |
Dead-type ATP-dependent RNA helicase (DbpB) from Staphylococcus aureus
|
|
EP0913474A3
(en)
*
|
1997-10-28 |
1999-12-29 |
Smithkline Beecham Corporation |
Dbpa, a helicase from Staphylococcus aureus
|
|
US6346393B1
(en)
*
|
1997-11-06 |
2002-02-12 |
Smithkline Beecham Corp. |
Polynucleotides encoding a ribonuclease s
|
|
US6312922B1
(en)
*
|
1998-02-09 |
2001-11-06 |
Genset |
Complementary DNAs
|
|
US6548633B1
(en)
|
1998-12-22 |
2003-04-15 |
Genset, S.A. |
Complementary DNA's encoding proteins with signal peptides
|
|
US6682919B1
(en)
|
1997-11-14 |
2004-01-27 |
Smithkline Beecham Corporation |
FabH
|
|
US6680195B1
(en)
*
|
1997-11-26 |
2004-01-20 |
Inhibitex, Inc. |
Extracellular matrix-binding proteins from staphylococcus aureus
|
|
CA2310217A1
(en)
*
|
1997-11-26 |
1999-06-03 |
Bioresearch Ireland |
Extracellular matrix-binding proteins from staphylococcus aureus
|
|
AU5903398A
(en)
*
|
1997-12-23 |
1999-07-12 |
Microcide Pharmaceuticals, Inc. |
Staphylococcus aureus histidine protein kinase essential genes
|
|
AU1726199A
(en)
|
1997-12-31 |
1999-07-19 |
Chiron Corporation |
Metastatic cancer regulated gene
|
|
US7432365B1
(en)
|
1998-01-27 |
2008-10-07 |
O'donnell Michael E |
DNA molecules encoding beta clamp proteins of gram positive bacteria
|
|
WO1999037661A1
(en)
|
1998-01-27 |
1999-07-29 |
The Rockefeller University |
Dna replication proteins of gram positive bacteria and their use to screen for chemical inhibitors
|
|
US6448037B1
(en)
*
|
1998-02-20 |
2002-09-10 |
Smithkline Beecham Corporation |
PgsA
|
|
US6767536B1
(en)
*
|
1998-03-02 |
2004-07-27 |
Ramot At Tel Aviv University Ltd. |
Recombinant Staphylococcus thioredoxin reductase and inhibitors thereof useful as antimicrobial agents
|
|
WO1999045123A1
(en)
*
|
1998-03-02 |
1999-09-10 |
Abbott Laboratories |
Recombinant staphylococcus thioredoxin reductase, and inhibitors thereof useful as antimicrobial agents
|
|
US6083924A
(en)
*
|
1998-03-12 |
2000-07-04 |
Smithkline Beecham Corporation |
DnaB of staphylococcus aureus
|
|
US6287804B1
(en)
*
|
1998-03-17 |
2001-09-11 |
Smithkline Beecham Corporation |
nrdG
|
|
US6555338B1
(en)
*
|
1998-03-17 |
2003-04-29 |
Smithkline Beecham Corporation |
NrdF from Staphylococcus aureus
|
|
GB9806762D0
(en)
*
|
1998-03-31 |
1998-05-27 |
Neutec Pharma Plc |
Treatment and diagnosis of staphylococcal infections
|
|
MX343752B
(es)
*
|
1998-05-01 |
2016-11-22 |
Novartis Vaccines & Diagnostics Inc |
Antigenos de neisseria meningitidis y composiciones que los contienen.
|
|
US6468743B1
(en)
*
|
1998-05-18 |
2002-10-22 |
Conagra Grocery Products Company |
PCR techniques for detecting microbial contaminants in foodstuffs
|
|
US6117662A
(en)
*
|
1998-05-22 |
2000-09-12 |
Smithkline Beecham Corporation |
Respiratory nitrate reductase alpha subunit
|
|
EP1087792A1
(en)
*
|
1998-06-17 |
2001-04-04 |
Smithkline Beecham Corporation |
NrdD
|
|
WO1999067360A2
(en)
*
|
1998-06-25 |
1999-12-29 |
Hemosol Inc. |
Media and methods for expansion of erythroid stem cells for the production of hemoglobin
|
|
EP1095133A4
(en)
*
|
1998-07-02 |
2003-06-11 |
Smithkline Beecham Corp |
MULTIMERE FTSZ PROTEINS AND THEIR USE
|
|
US6222014B1
(en)
*
|
1998-08-10 |
2001-04-24 |
Smithkline Beecham Corporation |
NrdE of staphylococcus aureus
|
|
WO2000011184A1
(en)
*
|
1998-08-25 |
2000-03-02 |
Schering Corporation |
Staphylococcus aureus polypeptides
|
|
US20020092987A1
(en)
*
|
1998-09-05 |
2002-07-18 |
Taehee Cho |
Photo detect device using quantum dots and materialization method thereof
|
|
US6222026B1
(en)
|
1998-09-08 |
2001-04-24 |
Smithkline Beecham Corporation |
Gcp
|
|
US6110723A
(en)
*
|
1998-11-12 |
2000-08-29 |
Smithkline Beecham Corporation |
Yfii pseudouridine synthase
|
|
US7101969B1
(en)
|
1998-12-03 |
2006-09-05 |
Targanta Therapeutics |
Compositions and methods involving an essential Staphylococcus aureus gene and its encoded protein
|
|
US6982153B1
(en)
|
1998-12-03 |
2006-01-03 |
Targanta Therapeutics, Inc. |
DNA sequences from staphylococcus aureus bacteriophage 77 that encode anti-microbial polypeptides
|
|
US6451556B1
(en)
|
1998-12-21 |
2002-09-17 |
Smithkline Beecham Corporation |
EF-Tu
|
|
US6448038B1
(en)
|
1999-01-26 |
2002-09-10 |
Smithkline Beecham Corporation |
BirA from staphylococcus aureus
|
|
WO2000044765A1
(en)
*
|
1999-01-27 |
2000-08-03 |
Smithkline Beecham Corporation |
Mvk
|
|
US6720139B1
(en)
|
1999-01-27 |
2004-04-13 |
Elitra Pharmaceuticals, Inc. |
Genes identified as required for proliferation in Escherichia coli
|
|
US6352840B1
(en)
*
|
1999-02-01 |
2002-03-05 |
Smithkline Beecham Corporation |
pskG
|
|
WO2000050433A2
(en)
*
|
1999-02-26 |
2000-08-31 |
Smithkline Beecham Corporation |
Staphylococcus aureus q13 polynucleotides, polypeptides and methods of use
|
|
WO2000056865A1
(en)
*
|
1999-03-22 |
2000-09-28 |
Smithkline Beecham Corporation |
Histidine kinase
|
|
WO2000058441A1
(en)
*
|
1999-03-26 |
2000-10-05 |
Smithkline Beecham Corporation |
STAPHYLOCOCCUS AUREUS ydjB RELATED TO THE LUXS AUTOINDUCER SYNTHESIS FAMILY
|
|
WO2000058331A1
(en)
*
|
1999-03-26 |
2000-10-05 |
Smithkline Beecham Corporation |
Mvd
|
|
US6107058A
(en)
*
|
1999-03-26 |
2000-08-22 |
Smithkline Beecham Corporation |
ispA from Staphylococcus aureus
|
|
AU4197600A
(en)
*
|
1999-04-07 |
2000-10-23 |
University Of Utah Research Foundation |
Eubacterial tmrna sequences and uses thereof
|
|
WO2000061778A1
(en)
*
|
1999-04-13 |
2000-10-19 |
Smithkline Beecham Corporation |
Staphylococcus aureus mvaa
|
|
US7101692B2
(en)
|
1999-04-15 |
2006-09-05 |
The Regents Of The University Of California |
Identification of sortase gene
|
|
CA2365523A1
(en)
*
|
1999-04-15 |
2000-10-26 |
The Regents Of The University Of California |
Identification of sortase gene
|
|
JP2002542821A
(ja)
*
|
1999-04-30 |
2002-12-17 |
ハイブリジェニックス・ソシエテ・アノニム |
ツーハイブリッドシステムのための原核ｄｎａコレクション、ヘリコバクター・ピロリのタンパク質−タンパク質相互作用およびその用途
|
|
WO2000066788A2
(en)
*
|
1999-05-03 |
2000-11-09 |
Gen-Probe Incorporated |
Polynucleotide probes for detection and quantitation of staphylococcus
|
|
US6821770B1
(en)
|
1999-05-03 |
2004-11-23 |
Gen-Probe Incorporated |
Polynucleotide matrix-based method of identifying microorganisms
|
|
WO2000071568A1
(en)
*
|
1999-05-04 |
2000-11-30 |
Smithkline Beecham Corporation |
Staphylococcal ica operon
|
|
WO2000068253A1
(en)
*
|
1999-05-05 |
2000-11-16 |
Sterrenbeld Biotechnologie North America, Inc. |
Dna promoter sequence for gene expression
|
|
JP2003524627A
(ja)
*
|
1999-05-06 |
2003-08-19 |
スミスクライン・ビーチャム・コーポレイション |
Ｆａｂｈ活性をモジュレートする方法
|
|
WO2000067575A1
(en)
*
|
1999-05-06 |
2000-11-16 |
Smithkline Beecham Corporation |
0623hk
|
|
US6194174B1
(en)
*
|
1999-05-12 |
2001-02-27 |
Smithkline Beecham Corporation |
Histidine kinase, 636 HK, of staphylococcus aureus
|
|
US6489139B1
(en)
|
1999-06-24 |
2002-12-03 |
Smithkline Beecham Corporation |
FabZ from Staphylococcus aureus
|
|
TR200607441T2
(tr)
*
|
1999-06-25 |
2007-02-21 |
Basf Aktiengesellschaft |
Membran sentezi ve membran nakli dahilinde corynemacterium glutamicum kodlayan proteinler.
|
|
SK18872001A3
(sk)
*
|
1999-06-25 |
2002-12-03 |
Basf Aktiengesellschaft |
Gény Corynebacterium glutamicum kódujúce proteíny zapojené do metabolizmu uhlíka a produkcie energie
|
|
CA2378010A1
(en)
*
|
1999-08-04 |
2001-02-15 |
Pharmacia & Upjohn Company |
Crystallization and structure determination of staphylococcus aureus thymidylate kinase
|
|
US6689595B1
(en)
|
1999-08-04 |
2004-02-10 |
Pharmacia & Upjohn Company |
Crystallization and structure determination of Staphylococcus aureus thymidylate kinase
|
|
CA2378032A1
(en)
|
1999-08-04 |
2001-02-15 |
Pharmacia & Upjohn Company |
Crystallization and structure determination of staphylococcus aureus udp-n-acetylenolpyruvylglucosamine reductase (s. aureus murb)
|
|
JP2003510025A
(ja)
*
|
1999-08-06 |
2003-03-18 |
スミスクライン・ビーチャム・コーポレイション |
Ｍａｐ
|
|
US6294357B1
(en)
*
|
1999-08-31 |
2001-09-25 |
Smithkline Beecham Corporation |
FabF from Staphylococcus aureus
|
|
EP1233974A4
(en)
*
|
1999-09-01 |
2004-09-22 |
Human Genome Sciences Inc |
GENES AND POLYPEPTIDEDES 37 I STAPHYLOCOCCUS AUREUS / I
|
|
WO2001018249A1
(en)
*
|
1999-09-10 |
2001-03-15 |
Smithkline Beecham Corporation |
Staphylococcus aureus kdtb polynucleotide and polypeptide
|
|
US6197546B1
(en)
|
1999-09-20 |
2001-03-06 |
Smithkline Beecham Corporation |
PcrA Helicase of Staphylococcus aureus
|
|
WO2001023403A1
(en)
*
|
1999-09-27 |
2001-04-05 |
Smithkline Beecham Corporation |
ypga CLADE GENES
|
|
CA2937907C
(en)
|
1999-09-28 |
2017-08-22 |
Geneohm Sciences Canada Inc. |
Nucleic acids, methods and kits for the detection of campylobacter
|
|
WO2001023418A1
(en)
*
|
1999-09-28 |
2001-04-05 |
Smithkline Beecham Corporation |
YphC
|
|
US6951729B1
(en)
|
1999-10-27 |
2005-10-04 |
Affinium Pharmaceuticals, Inc. |
High throughput screening method for biological agents affecting fatty acid biosynthesis
|
|
WO2001030806A1
(en)
*
|
1999-10-28 |
2001-05-03 |
Smithkline Beecham Corporation |
Polynucleotides and polypeptides involved in biofilm biology and their uses
|
|
WO2001032022A1
(en)
*
|
1999-11-04 |
2001-05-10 |
Smithkline Beecham Corporation |
YtgP
|
|
AU2041901A
(en)
|
1999-11-09 |
2001-06-06 |
Elitra Pharmaceuticals, Inc. |
Genes essential for microbial proliferation and antisense thereto
|
|
WO2001038345A1
(en)
*
|
1999-11-24 |
2001-05-31 |
Smithkline Beecham Corporation |
Regulatable fabh constructs
|
|
JP2003520034A
(ja)
|
1999-12-23 |
2003-07-02 |
ヴィマックス リミテッド |
ビルレンス遺伝子、タンパク質、およびそれらの用途
|
|
RU2240327C2
(ru)
*
|
1999-12-23 |
2004-11-20 |
Вмакс Лимитед |
Ген и белок вирулентности и их использование
|
|
US6316211B1
(en)
|
2000-01-26 |
2001-11-13 |
Smithkline Beecham Corporation |
ThdF
|
|
JPWO2001055397A1
(ja)
*
|
2000-01-28 |
2004-01-08 |
平松 啓一 |
新規ポリペプチドＶｒａＳ及びＶｒａＲ
|
|
JP2005229801A
(ja)
*
|
2000-01-28 |
2005-09-02 |
Keiichi Hiramatsu |
新規ポリペプチドＨｍｒＡ及びＨｍｒＢ
|
|
AU2001233099A1
(en)
*
|
2000-01-31 |
2001-08-07 |
Pharmacia And Upjohn Company |
Crystallization and structure determination of staphylococcus aureus nad synthetase
|
|
JP2003531585A
(ja)
|
2000-02-24 |
2003-10-28 |
アナディーズ ファーマスーティカルズ，アイエヌシー． |
ブドウ球菌ＧＴＰ−結合タンパク質をコードするブドウ球菌ＧＴＰアーゼＯｂｇヌクレオチド配列
|
|
WO2001064855A1
(en)
*
|
2000-03-01 |
2001-09-07 |
Smithkline Beecham Corporation |
Clpp
|
|
WO2001077365A2
(en)
*
|
2000-04-06 |
2001-10-18 |
Pharmacia & Upjohn Company |
Antimicrobial methods and materials
|
|
WO2001088186A2
(en)
*
|
2000-05-19 |
2001-11-22 |
Institut Pasteur |
Methods for detecting and identifying a gram positive bacteria in a sample
|
|
GB0014907D0
(en)
|
2000-06-20 |
2000-08-09 |
Univ Sheffield |
Antigenic polypeptides
|
|
US6864080B2
(en)
|
2000-06-30 |
2005-03-08 |
Pharmacia & Upjohn Company |
Crystallization and structure of Staphylococcus aureus peptide deformylase
|
|
WO2002006491A1
(fr)
*
|
2000-07-18 |
2002-01-24 |
Center For Advanced Science And Technology Incubation, Ltd. |
Isopentenyl pyrophosphate isomerase
|
|
EP1399562A2
(en)
*
|
2000-07-19 |
2004-03-24 |
PHARMACIA & UPJOHN COMPANY |
Complete nucleotide sequence of staphylococcus aureus ribosomal protein gene, s20 and methods for the identification of antibacterial substances
|
|
IL154751A0
(en)
*
|
2000-08-03 |
2003-10-31 |
|
Humanized antibodies, recombination vectors, transgenic vectors and methods for the preparation of humanized antibodies from transgenic animals
|
|
SE0003573D0
(sv)
*
|
2000-10-04 |
2000-10-04 |
Bengt Guss |
Method and means for producing novel von Willebrand factor binding proteins and their use in biotechnology
|
|
US7048926B2
(en)
|
2000-10-06 |
2006-05-23 |
Affinium Pharmaceuticals, Inc. |
Methods of agonizing and antagonizing FabK
|
|
US8168773B2
(en)
|
2000-10-06 |
2012-05-01 |
Novozymes, Inc. |
Methods for monitoring multiple gene expression
|
|
CA2433386C
(en)
|
2000-12-19 |
2006-11-21 |
Targanta Therapeutics Inc. |
Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r9
|
|
AT410798B
(de)
|
2001-01-26 |
2003-07-25 |
Cistem Biotechnologies Gmbh |
Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
|
|
EP1227152A1
(en)
*
|
2001-01-30 |
2002-07-31 |
Société des Produits Nestlé S.A. |
Bacterial strain and genome of bifidobacterium
|
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
|
CA2348042A1
(en)
|
2001-06-04 |
2002-12-04 |
Ann Huletsky |
Sequences for detection and identification of methicillin-resistant staphylococcus aureus
|
|
EP2339344A1
(en)
*
|
2001-06-15 |
2011-06-29 |
Inhibitex, Inc. |
Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
|
|
WO2003025004A2
(en)
*
|
2001-09-18 |
2003-03-27 |
Affinium Pharmaceuticals, Inc. |
Purified bacterial polypeptides involved in nucleic acid processing
|
|
AU2002328222A1
(en)
*
|
2001-09-21 |
2003-04-01 |
Affinium Pharmaceuticals, Inc. |
Purified bacterial polypeptides involved in protein processing
|
|
US20050214773A1
(en)
*
|
2001-09-21 |
2005-09-29 |
Affinium Pharmaceuticals, Inc. |
Novel purified polypeptides from bacteria
|
|
FR2831187A1
(fr)
*
|
2001-10-22 |
2003-04-25 |
Univ Aix Marseille Ii |
Methode de determination de l'activite bacteriostatique ou bactericide des agents antibiotiques par pcr quantitative
|
|
US20040029129A1
(en)
*
|
2001-10-25 |
2004-02-12 |
Liangsu Wang |
Identification of essential genes in microorganisms
|
|
US20050203280A1
(en)
*
|
2001-11-29 |
2005-09-15 |
Mcmichael John C. |
Alloiococcus otitidis open reading frames (orfs) encoding polypeptide antigens, immunogenic compositions and uses thereof
|
|
WO2003066849A2
(en)
*
|
2002-02-04 |
2003-08-14 |
Affinium Pharmaceuticals, Inc. |
Novel purified polypeptides from staphylococcus aureus
|
|
US6946267B2
(en)
*
|
2002-03-13 |
2005-09-20 |
Dr. Chip Biotechnology Inc. |
Method for detecting Staphylococcus aureus
|
|
WO2003084986A2
(en)
*
|
2002-04-04 |
2003-10-16 |
Affinium Pharmaceuticals, Inc. |
Novel purified polypeptides involved in cellular metabolism
|
|
WO2004009839A2
(de)
*
|
2002-07-18 |
2004-01-29 |
Henkel Kommanditgesellschaft Auf Aktien |
Obligonukleotide zum nachweis von mikroorganismen
|
|
JP2005532818A
(ja)
*
|
2002-07-18 |
2005-11-04 |
ヘンケル・コマンディットゲゼルシャフト・アウフ・アクチエン |
微生物の検出
|
|
JPWO2004020635A1
(ja)
*
|
2002-08-28 |
2005-12-15 |
株式会社テクノネットワーク四国 |
バクテリオファージおよび細菌感染症治療剤
|
|
US20060115819A1
(en)
|
2002-12-06 |
2006-06-01 |
Sofie Claeys |
Detection, identification and differentiation of eubacterial taxa using a hybridization assay
|
|
WO2005005630A2
(en)
*
|
2003-07-08 |
2005-01-20 |
Umc Utrecht Holding B.V. |
Therapeutic use of lpi, a staphylococcal lectin pathway inhibitor in inflammatory diseases
|
|
FR2857375B1
(fr)
*
|
2003-07-10 |
2007-11-09 |
Biomerieux Sa |
Procede de detection et/ou d'identification de bacteries de genre staphylococcus
|
|
EP1648928A2
(en)
|
2003-07-11 |
2006-04-26 |
Affinium Pharmaceuticals, Inc. |
Novel purified polypeptides from staphylococcus aureus
|
|
WO2005056817A2
(en)
|
2003-12-09 |
2005-06-23 |
Biomerieux, Inc. |
Method for recovering microorganisms from a sample
|
|
US7429464B2
(en)
|
2003-12-09 |
2008-09-30 |
Biomerieux, Inc. |
Methods for detecting bacterial pathogens
|
|
DE602004019564D1
(de)
|
2003-12-09 |
2009-04-02 |
Bio Merieux Inc |
Verfahren zum nachweis bakterieller krankheitserreger
|
|
CN1918176A
(zh)
|
2004-02-18 |
2007-02-21 |
默克公司 |
用于诱导针对金黄色葡萄球菌的保护性免疫反应的多肽
|
|
GB0409559D0
(en)
*
|
2004-04-29 |
2004-06-02 |
Univ Sheffield |
Polypeptide
|
|
EP1791560A4
(en)
*
|
2004-09-17 |
2009-01-14 |
Merck & Co Inc |
POLYPEPTIDES FOR INDUCING A PROTECTIVE IMMUNE RESPONSE AGAINST STAPHYLOCOCCUS AUREUS
|
|
US20070264278A1
(en)
*
|
2004-09-17 |
2007-11-15 |
Anderson Annaliesa S |
Polypeptides for Inducing a Protective Immune Response Against Staphylococcus Aureus
|
|
ES2730275T3
(es)
|
2004-09-22 |
2019-11-11 |
Glaxosmithkline Biologicals Sa |
Composición inmunógena para uso en vacunación contra estafilococos
|
|
WO2006078680A2
(en)
|
2005-01-21 |
2006-07-27 |
Merck & Co., Inc. |
Polypeptides for inducing a protective immune response against staphylococcus aureus
|
|
AU2006212754B2
(en)
*
|
2005-02-07 |
2009-09-03 |
Gen-Probe Incorporated |
Compositions and methods for detecting Group B Streptococci
|
|
CA2606253A1
(en)
*
|
2005-04-21 |
2006-10-26 |
Uti Limited Partnership |
Pcr for mrsa sccmec typing
|
|
US11834720B2
(en)
*
|
2005-10-11 |
2023-12-05 |
Geneohm Sciences, Inc. |
Sequences for detection and identification of methicillin-resistant Staphylococcus aureus (MRSA) of MREJ types xi to xx
|
|
AU2007221321B2
(en)
*
|
2006-02-22 |
2012-06-28 |
The Texas A & M University System |
Antibodies recognizing a highly expressed putative antigen of CA-MRSA and methods of use
|
|
NZ570805A
(en)
|
2006-03-30 |
2011-10-28 |
Glaxosmithkline Biolog Sa |
Vaccine comprising Type 5 and Type 8 capsular polysaccharides from Staphyloccocus aureus
|
|
DK2020449T3
(da)
*
|
2006-04-24 |
2013-01-14 |
Sigma Alimentos Sa De Cv |
Fremgangsmåde til detektion og multipel, simultan kvantificering af patogener ved hjælp af real-time polymerasekædereaktion
|
|
ATE514794T1
(de)
*
|
2006-05-12 |
2011-07-15 |
Gen Probe Inc |
Zusammensetzungen und verfahren für den nachweis von enterokokken-nukleinsäuren
|
|
CA2654460A1
(en)
*
|
2006-05-23 |
2007-11-29 |
Tufts University |
Methods and compositions for the treatment and prevention of staphylococcus aureus infections through interference with opuc operon interaction with trap
|
|
EP2064325B1
(en)
|
2006-09-01 |
2011-12-07 |
Therapeutic Human Polyclonals, Inc. |
Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals
|
|
WO2008043185A1
(en)
*
|
2006-10-13 |
2008-04-17 |
Universite Laval |
Reliable detection of vancomycin-intermediate staphylococcus aureus
|
|
CN101627133A
(zh)
*
|
2007-01-08 |
2010-01-13 |
株式会社美迪基尼斯 |
用于金黄色葡萄球菌检测的dna芯片
|
|
JP2010524454A
(ja)
|
2007-04-19 |
2010-07-22 |
モレキュラー ディテクション インコーポレーテッド |
抗生物質耐性細菌の検出および分析のための方法、組成物、およびキット
|
|
KR20100072228A
(ko)
*
|
2007-08-31 |
2010-06-30 |
유니버시티 오브 시카고 |
스타필로코커스 폐 질환 및 상태에 대한 면역화와 관련된 방법 및 조성물
|
|
US9181329B2
(en)
|
2007-08-31 |
2015-11-10 |
The University Of Chicago |
Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions
|
|
US9045442B2
(en)
*
|
2007-12-21 |
2015-06-02 |
University Of Notre Dame Du Lac |
Antibacterial compounds and methods of using same
|
|
RU2010144789A
(ru)
*
|
2008-04-01 |
2012-05-10 |
Метаметрикс Клиникал Лэборетери (Us) |
Процесс и способ мониторинга желудочно-кишечной микрофлоры
|
|
US8758765B2
(en)
*
|
2008-07-29 |
2014-06-24 |
The University Of Chicago |
Compositions and methods related to Staphylococcal bacterium proteins
|
|
US8318180B2
(en)
*
|
2008-09-30 |
2012-11-27 |
University Of Maryland, Baltimore |
Protective vaccine against Staphylococcus aureus biofilms comprising cell wall-associated immunogens
|
|
CA2758687A1
(en)
*
|
2008-11-14 |
2010-05-20 |
Gen-Probe Incorporated |
Compositions, kits and methods for detection of campylobacter nucleic acid
|
|
EP2376111A4
(en)
|
2008-11-26 |
2013-01-09 |
Merck Sharp & Dohme |
POLYPEPTIDES FOR INDUCING A PROTECTIVE IMMUNE RESPONSE AGAINST STAPHYLOCOCCUS AUREUS
|
|
CN102292105A
(zh)
|
2008-11-26 |
2011-12-21 |
默沙东公司 |
用于诱导抗金黄色葡萄球菌的保护性免疫应答的多肽
|
|
HRP20160274T1
(hr)
|
2009-04-03 |
2016-04-08 |
University Of Chicago |
Pripravci i metode vezane za varijante proteina a (spa)
|
|
AU2010264538B2
(en)
|
2009-06-22 |
2013-10-03 |
Wyeth Llc |
Immunogenic compositions of Staphylococcus aureus antigens
|
|
EP2555794A4
(en)
|
2010-04-05 |
2014-01-15 |
Univ Chicago |
COMPOSITIONS AND METHODS RELATING TO PROTEIN A (SPA) ANTIBODIES AS IMMUNE REACTION AMPLIFIERS
|
|
AU2011274367B2
(en)
|
2010-07-02 |
2015-04-23 |
The University Of Chicago |
Compositions and methods related to protein A (SpA) variants
|
|
EP2593133A4
(en)
|
2010-07-13 |
2014-11-26 |
Merck Sharp & Dohme |
STAPHYLOCOCCUS AUREUS SURFACE PROTEIN SA1789 AND PROTECTIVE VACCINE BASED ON IT
|
|
JP5793194B2
(ja)
|
2010-09-09 |
2015-10-14 |
ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ |
感染防御ブドウ球菌抗原が関与する方法および組成物
|
|
WO2012065034A1
(en)
|
2010-11-12 |
2012-05-18 |
Merck Sharp & Dohme Corp. |
Enolase peptide conjugate vaccines against staphylococcus aureus
|
|
EP2694534B1
(en)
*
|
2011-04-08 |
2018-06-20 |
Evaxion Biotech ApS |
Proteins and nucleic acids useful in vaccines targeting staphylococcus aureus
|
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
|
WO2013162746A1
(en)
|
2012-04-26 |
2013-10-31 |
University Of Chicago |
Staphylococcal coagulase antigens and methods of their use
|
|
EP2872173A4
(en)
|
2012-07-10 |
2016-03-23 |
Merck Sharp & Dohme |
PROTECTIVE VACCINE BASED ON THE STAPHYLOCOCCUS AUREUS PROTEIN SA2493
|
|
EP2968603B1
(en)
|
2013-03-15 |
2020-06-24 |
Techulon Inc. |
Antisense molecules for treatment of staphylococcus aureus infection
|
|
WO2016049586A2
(en)
|
2014-09-25 |
2016-03-31 |
University Of Notre Dame Du Lac |
Non-beta lactam antibiotics
|
|
US11519016B2
(en)
|
2016-01-21 |
2022-12-06 |
T2 Biosystems, Inc. |
NMR methods and systems for the rapid detection of bacteria
|
|
WO2018049404A1
(en)
|
2016-09-12 |
2018-03-15 |
University Of Notre Dame Du Lac |
Compounds for the treatment of clostridium difficile infection
|
|
WO2018200887A1
(en)
*
|
2017-04-26 |
2018-11-01 |
The Translational Genomics Research Institute |
Methods and assays for subtyping staphylococcus aureus clonal complex 8 strains
|
|
US11572591B2
(en)
|
2017-04-26 |
2023-02-07 |
The Translational Genomics Research Institute |
Methods and assays for subtyping Staphylococcus aureus clonal complex 8 strains
|
|
MX2020005875A
(es)
|
2017-12-05 |
2020-10-08 |
Bioplx Inc |
Métodos y composiciones para prevenir la infección microbiana.
|
|
CA3139981A1
(en)
|
2019-05-14 |
2020-11-19 |
The University Of Chicago |
Methods and compositions comprising staphylococcus protein a (spa) variants
|
|
WO2020245764A2
(en)
*
|
2019-06-06 |
2020-12-10 |
Tata Consultancy Services Limited |
System and method for combating pseudomonas aeruginosa and staphylococcus aureus infections
|
|
AU2020295398A1
(en)
*
|
2019-06-19 |
2021-12-23 |
Pioneer Hi-Bred International, Inc. |
Pod shatter tolerance in Brassica plants
|
|
US12528882B2
(en)
|
2019-09-13 |
2026-01-20 |
The University Of Chicago |
Methods and compositions for treating staphylococcal infections
|
|
CN110982757B
(zh)
*
|
2019-12-30 |
2021-04-06 |
浙江工业大学 |
阴沟肠杆菌zjph1903及应用
|
|
KR102691617B1
(ko)
*
|
2021-12-08 |
2024-08-13 |
대한민국 |
작물의 초형을 조절하는 OsHDSTART1 유전자 및 이의 용도
|
|
CN116024371B
(zh)
*
|
2022-11-28 |
2024-12-13 |
迪飞医学科技(南京)有限公司 |
一种多重qPCR检测病原菌的引物探针组、试剂盒和检测方法
|